fremanezumab

Ukraine

Drugs containing this active substance

ADJOVI™

The drug is intended for the prevention of migraine in adults who experience headache attacks at least 4 days per month.

Form: solution for injection

Active substance	Dosage
fremanezumab	225 mg/1.5 ml

Manufacturer: Wetter Pharma-Fertigung GmbH & Co KG (manufacturing of medicinal product, primary packaging, secondary packaging, quality control of medicinal product)